Related references
Note: Only part of the references are listed.Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii et al.
HEPATOLOGY RESEARCH (2010)
Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma
Kazuomi Ueshima et al.
ONCOLOGY (2010)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Is the addition of subcutaneous interferon-α-2b beneficial?
Satoe Takaki-Hamabe et al.
HEPATOLOGY RESEARCH (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Ryul Eun et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases
Kiminori Uka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
Jun Yong Park et al.
CANCER (2007)
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
Iwao Ikai et al.
HEPATOLOGY RESEARCH (2007)
Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis
Takashi Someya et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
S Obi et al.
CANCER (2006)
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil;: role of type I interferon receptor expression
H Ota et al.
BRITISH JOURNAL OF CANCER (2005)
Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
JY Cheong et al.
HEPATOLOGY RESEARCH (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
T Yamasaki et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: Prognostic factors
A Hamada et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
JA Davila et al.
GASTROENTEROLOGY (2004)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis - Analysis of 48 cases
E Ando et al.
CANCER (2002)
Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis
S Kaneko et al.
ONCOLOGY (2002)
Remission and survival following monthly intraarterial cisplatinum in nonresectable hepatoma
WS Court et al.
CANCER INVESTIGATION (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
